The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

protection

Short communication: Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection

April 22, 2010 - 11:25 -- Patrick Sampao
Author(s): 
Manuel A. Giraldo, Gabriela Arevalo-Pinzon, Jose Rojas-Caraballo, Alvaro Mongui, Raul Rodriguez, Manuel A. Patarroyo
Reference: 
Vaccine, Volume 28, Issue 1, 10 December 2009, Pages 7-13

The immunogenicity of rPvMSP10 was tested in Aotus monkeys, comparing responses induced by formulations with Freund's adjuvant, Montanide ISA720 or aluminum hydroxide.

Medical Treatment: 

Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria and induction of protective antibodies by sub-patent malaria infections, in Daraweesh

February 4, 2010 - 15:38 -- Kabogo Ndegwa
Author(s): 
Hayder A. Giha, Amre Nasr, Nnaemeka C. Iriemenam, Halima A. Balogun, David Arnot, Thor G. Theanderf, Marita Troye-Blomberg, Klavs Berzins and Gehad ElGhazali
Reference: 
Vaccine, Volume 28, Issue 7, 17 February 2010, Pages 1732-1739

In conclusion, this report suggests a protective effect for IgG subclasses to Pf332-C231 antigen against malaria.

Subscribe to RSS - protection